Navamedic ASA: Mandatory notice of trade
Navamedic ASA (NAVA) · publisert 10. mars 2025 kl. 17:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Philip Slätis | Primary insider: Commercial Director | Kjøp | 5 297 | 19,84 NOK | 10. mars 2025 | – | Oslo Stock Exchange |
Vedlegg
- Navamedic_Notification_of_trade.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, March 10, 2025: Philip Slätis, Commercial Director and a primary insider
of Navamedic ASA, has today bought 5,297 Navamedic ASA shares at an average
price of NOK 19.84 per share. See attachment for further details about the
transaction. Following this transaction, Philip Slätis holds 10,000 shares in
the company.
This release is an announcement issued pursuant to legal information obligations
and is subject of the disclosure requirements pursuant to the Market Abuse
Regulation (MAR) Article 19 no. 3 and section 5-12 of the Norwegian Securities
Trading Act